Copyright
©The Author(s) 2021.
World J Gastroenterol. May 14, 2021; 27(18): 2219-2237
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2219
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2219
Time | Placebo | Active treated | ||||
Females | Males | P value | Females | Males | P value | |
0 | 116 ± 20 | 130 ± 11 | 0.03 | 111 ± 23 | 114 ± 21 | 0.9 |
2 wk | 123 ± 29 | 120 ± 23 | 0.7 | 122 ± 24 | 118 ± 27 | 0.6 |
1 mo | 123 ± 26 | 121 ± 26 | 0.8 | 126 ± 24 | 119 ± 29 | 0.4 |
3 mo | 112 ± 24 | 118 ± 26 | 0.2 | 132 ± 23 | 131 ± 25 | 0.9 |
- Citation: El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World J Gastroenterol 2021; 27(18): 2219-2237
- URL: https://www.wjgnet.com/1007-9327/full/v27/i18/2219.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i18.2219